These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 35716975)

  • 21. Formulation and evaluation of insulin dry powder for inhalation.
    Mahesh Kumar T; Misra A
    Drug Dev Ind Pharm; 2006 Jul; 32(6):677-86. PubMed ID: 16885123
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A New Role of Fine Excipient Materials in Carrier-Based Dry Powder Inhalation Mixtures: Effect on Deagglomeration of Drug Particles During Mixing Revealed.
    Shalash AO; Elsayed MMA
    AAPS PharmSciTech; 2017 Nov; 18(8):2862-2870. PubMed ID: 28421352
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of realistic inspiratory flow profiles on fine particle fractions of dry powder aerosol formulations.
    Martin GP; Marriott C; Zeng XM
    Pharm Res; 2007 Feb; 24(2):361-9. PubMed ID: 17177114
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preparation and Evaluation of Surface Modified Lactose Particles for Improved Performance of Fluticasone Propionate Dry Powder Inhaler.
    Singh DJ; Jain RR; Soni PS; Abdul S; Darshana H; Gaikwad RV; Menon MD
    J Aerosol Med Pulm Drug Deliv; 2015 Aug; 28(4):254-67. PubMed ID: 25517187
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Humidity-induced changes of the aerodynamic properties of dry powder aerosol formulations containing different carriers.
    Zeng XM; MacRitchie HB; Marriott C; Martin GP
    Int J Pharm; 2007 Mar; 333(1-2):45-55. PubMed ID: 17064863
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of SCF-engineered particle-based lactose blends in passive dry powder inhalers.
    Schiavone H; Palakodaty S; Clark A; York P; Tzannis ST
    Int J Pharm; 2004 Aug; 281(1-2):55-66. PubMed ID: 15288343
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polymer coating of carrier excipients modify aerosol performance of adhered drugs used in dry powder inhalation therapy.
    Traini D; Scalia S; Adi H; Marangoni E; Young PM
    Int J Pharm; 2012 Nov; 438(1-2):150-9. PubMed ID: 22964399
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of mild processing pressures on the performance of dry powder inhaler formulations for inhalation therapy. 1: Budesonide and lactose.
    Marek SR; Donovan MJ; Smyth HD
    Eur J Pharm Biopharm; 2011 May; 78(1):97-106. PubMed ID: 21182942
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dispersibility of lactose fines as compared to API in dry powders for inhalation.
    Thalberg K; Åslund S; Skogevall M; Andersson P
    Int J Pharm; 2016 May; 504(1-2):27-38. PubMed ID: 26965200
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of surface processing of lactose carrier particles on dry powder inhalation properties of salbutamol sulfate.
    Iida K; Inagaki Y; Todo H; Okamoto H; Danjo K; Luenberger H
    Chem Pharm Bull (Tokyo); 2004 Aug; 52(8):938-42. PubMed ID: 15304985
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Physical characteristics and aerosolization performance of insulin dry powders for inhalation prepared by a spray drying method.
    You Y; Zhao M; Liu G; Tang X
    J Pharm Pharmacol; 2007 Jul; 59(7):927-34. PubMed ID: 17637186
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preparation of dry powder inhalation with lactose carrier particles surface-coated using a Wurster fluidized bed.
    Iida K; Todo H; Okamoto H; Danjo K; Leuenberger H
    Chem Pharm Bull (Tokyo); 2005 Apr; 53(4):431-4. PubMed ID: 15802846
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of magnesium stearate surface coating method on the aerosol performance and permeability of micronized fluticasone propionate.
    Kumar V; Sethi B; Yanez E; Leung DH; Ghanwatkar YY; Cheong J; Tso J; Narang AS; Nagapudi K; Mahato RI
    Int J Pharm; 2022 Mar; 615():121470. PubMed ID: 35041913
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Formulating powder-device combinations for salmeterol xinafoate dry powder inhalers.
    Hassoun M; Ho S; Muddle J; Buttini F; Parry M; Hammond M; Forbes B
    Int J Pharm; 2015 Jul; 490(1-2):360-7. PubMed ID: 25987210
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development and characterization of meropenem dry powder inhaler formulation for pulmonary drug delivery.
    Muneer S; Wang T; Rintoul L; Ayoko GA; Islam N; Izake EL
    Int J Pharm; 2020 Sep; 587():119684. PubMed ID: 32736016
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of surface covering of lactose carrier particles on dry powder inhalation properties of salbutamol sulfate.
    Iida K; Hayakawa Y; Okamoto H; Danjo K; Luenbergerb H
    Chem Pharm Bull (Tokyo); 2003 Dec; 51(12):1455-7. PubMed ID: 14646332
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ternary Dry Powder Agglomerate Inhalation Formulation of Melatonin With Air Jet Mixing to Improve In Vitro And In Vivo Performance.
    Zhang Q; Kou S; Cui Y; Dong J; Ye Y; Wang Y; Lu R; Li X; Nie Y; Shi K; Chen F; Hall P; Chen X; Wang Z; Jiang X
    J Pharm Sci; 2024 Feb; 113(2):434-444. PubMed ID: 37995838
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of intrinsic fines in the performance change of expired lactose carriers for DPI applications.
    Bungert N; Kobler M; Scherließ R
    Eur J Pharm Biopharm; 2022 Jun; 175():7-12. PubMed ID: 35470067
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dry powders for inhalation containing monoclonal antibodies made by thin-film freeze-drying.
    Hufnagel S; Xu H; Sahakijpijarn S; Moon C; Chow LQM; Williams Iii RO; Cui Z
    Int J Pharm; 2022 Apr; 618():121637. PubMed ID: 35259440
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effect of mixing of fine carrier particles on dry powder inhalation property of salbutamol sulfate (SS)].
    Iida K; Leuenberger H; Fueg LM; Müller-Walz R; Okamoto H; Danjo K
    Yakugaku Zasshi; 2000 Jan; 120(1):113-9. PubMed ID: 10655787
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.